Sequegenics

Sequegenics

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Sequegenics is a private, early-stage company offering sequencing and bioinformatics services to the research and clinical diagnostics markets. Based in the biotech hub of San Diego, the company is positioned to capitalize on the growing demand for genomic data generation and interpretation. Its business model is focused on providing essential tools and services to academic, pharmaceutical, and healthcare institutions. As a service provider, its success hinges on technological competitiveness, operational efficiency, and the ability to secure contracts and partnerships.

Genetics & GenomicsDiagnostics

Technology Platform

Utilizes next-generation sequencing (NGS) technologies and bioinformatics pipelines for genomic data generation and analysis.

Opportunities

The rapid adoption of precision medicine and genomic profiling in clinical diagnostics creates a growing demand for reliable sequencing services.
Falling costs and expanding applications in drug discovery and agricultural biotech open diverse market segments beyond healthcare.

Risk Factors

Faces intense competition from large CROs, specialized labs, and academic core facilities.
Rapid technological obsolescence requires continuous capital investment.
Clinical service revenue is subject to stringent regulation and potential reimbursement challenges.

Competitive Landscape

The genomics services market is fragmented and highly competitive. Sequegenics competes with large, diversified contract research organizations (CROs), established clinical diagnostic labs, and university core facilities. Differentiation requires superior technology, faster turnaround, lower cost, or specialized analytical expertise.